Related Experiment Videos
Structure-activity relationship of fluoroquinolone in Escherichia coli
Abstract:
Structure-activity relationship of 20 fluoroquinolones was studied using the susceptible and 4 resistant Escherichia coli which were developed against 4 fluoroquinolones [ciprofloxacin (1), KR-10755 (6), norfloxacin (2), and ofloxacin (3)] in our laboratory. The C-7 and C-8 substituents of fluoroquinolone were important in various functions such as the inhibitory activity on DNA gyrase, permeability, and efflux. Among 20 fluoroquinolones, compounds with a 3-methyl-3,7-diazabicyclo[3.3.0]octan-1(5)-ene-7-yl substituent at the C-7 position or a chlorine substituent at the C-8 position showed a good inhibitory activity on DNA gyrase (especially a mutated DNA gyrase). Compounds with a 3,7-diazabicyclo [3.3.0]octan-1(5)-ene-7-yl substituent at the C-7 position showed good permeability in the susceptible and resistant strains, while compounds with a fluorine substituent at the C-8 position were less effluxed from cells.
Insights
Structure-activity relationships of fluoroquinolones were investigated. Substituents at the C-7 and C-8 positions significantly impact DNA gyrase inhibition, cellular permeability, and drug efflux in Escherichia coli.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Pharmacology
Background:
- Fluoroquinolones are critical antibiotics targeting bacterial DNA gyrase.
- Antibiotic resistance necessitates understanding structure-activity relationships for novel drug development.
- Escherichia coli serves as a model organism for studying fluoroquinolone efficacy and resistance mechanisms.
Purpose of the Study:
- To elucidate the structure-activity relationship (SAR) of 20 fluoroquinolone derivatives.
- To investigate the impact of C-7 and C-8 substituents on DNA gyrase inhibition, bacterial permeability, and drug efflux.
- To identify key structural features conferring activity against both susceptible and resistant Escherichia coli strains.
Main Methods:
- Synthesis and evaluation of 20 distinct fluoroquinolone compounds.
- Assessment of inhibitory activity against wild-type and resistant DNA gyrase enzymes.
- Measurement of drug permeability and efflux in susceptible and resistant Escherichia coli.
Main Results:
- Specific C-7 and C-8 substituents were identified as crucial for potent DNA gyrase inhibition, particularly against mutated enzymes.
- The 3,7-diazabicyclo[3.3.0]octan-1(5)-ene-7-yl group at C-7 enhanced cellular permeability.
- A C-8 fluorine substituent was associated with reduced drug efflux from bacterial cells.
Conclusions:
- Structural modifications at the C-7 and C-8 positions of fluoroquinolones can modulate antibacterial activity and overcome resistance.
- Optimizing substituents can improve DNA gyrase inhibition, cellular penetration, and reduce efflux, leading to enhanced efficacy.
- This SAR study provides a foundation for designing next-generation fluoroquinolones effective against resistant bacterial infections.